United States: Big Four Health Committee Leaders Release Request For Information On Regulation Of Cannabidiol - Foley Hoag LLP
Published
Congressional leaders in both chambers are seeking public input on the potential development of a new regulatory pathway for hemp-derived cannabidiol (CBD) products.
Full Article